{
  "Disease": [
    {"role": "user", "content": "Please identify the \"Disease\" entities in the following paragraph.\n\nParagraph: Although both domains of the VHL protein contribute to regulation of CA12 expression , the elongin binding domain alone could effectively regulate CA9 expression .\n\nLet's think step by step."},
    {"role": "assistant", "content": "1. CA12: It is a specific protein identified in the paragraph. It is not explicitly stated that CA12 is a disease, but it could be a marker or a target of certain diseases.\n2. CA9: It is another specific protein identified in the paragraph. Like CA12, it is not explicitly stated that CA9 is a disease, but it could be a marker or a target of certain diseases.\n\nTherefore, the disease entities in the paragraph are not explicitly mentioned. The paragraph is discussing the regulatory roles of the VHL protein and its domains (elongin binding domain) in relation to CA12 and CA9 expression."},
    {"role": "user", "content": "Please remove irrelevant entities and only keep the entities that clearly refer to Disease."},
    {"role": "assistant", "content": "There are no explicit mentions of diseases in the paragraph. The paragraph is discussing the regulatory roles of the VHL protein and its domains (elongin binding domain) in relation to CA12 and CA9 expression.\n\nTherefore, there are no disease entities in the paragraph."},
    {"role": "user", "content": "Please present the valid entities as a Markdown table with one column \"Disease\".\n\nMake sure to present the entities precisely in the same words as in the original paragraph."},
    {"role": "assistant", "content": "| Disease |\n| --- |\n| N/A |\n\nThe paragraph does not mention any diseases. It discusses the regulatory roles of the VHL protein and its domains (elongin binding domain) in relation to CA12 and CA9 expression."}
  ]
}